1-1 of 1
Keywords: Pregnane-oximino-amino-alkyl-ether
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pregnane-Oximino-Alkyl-Amino-Ether Compound as a Novel Class of TGR5 Receptor Agonist Exhibiting Antidiabetic and Anti-Dyslipidemic Activities

Available to Purchase
Subject Area:
Pharmacology
Jyoti Gupta, Dharmendra P. Singh, Prem C. Verma, Neha Rahuja, Rohit Srivastava, Ishbal Ahmad, Natasha Jaiswal, Harish Kumar, Anand P. Gupta, Varsha Gupta, Anamika Misra, Hari N. Kushwaha, Bhawani Singh, Sheo K. Singh, Anil K. Dwivedi, Jiaur R. Gayen, Sabyasachi Sanyal, Arvind K. Srivastava, Ram Pratap, Akhilesh K. Tamrakar
Journal: Pharmacology
Pharmacology (2022) 107 (1-2): 54–68.
https://doi.org/10.1159/000519721
Published Online: 23 November 2021
... Pratap; Akhilesh K. Tamrakar Introduction: The present study deals with the synthesis of pregnane-oximino-amino-alkyl-ethers and their evaluation for antidiabetic and anti-dyslipidemic activities in validated animal and cell culture models. Methods: The effect on glucose tolerance was measured in sucrose...
View articletitled, Pregnane-Oximino-Alkyl-Amino-Ether Compound as a Novel Class of TGR5 Receptor Agonist Exhibiting Antidiabetic and Anti-Dyslipidemic Activities
Open the PDF for Pregnane-Oximino-Alkyl-Amino-Ether Compound as a Novel Class of TGR5 Receptor Agonist Exhibiting Antidiabetic and Anti-Dyslipidemic Activities in another window